Contraception Use of MOUNJARO may reduce the efficacy of oral hormonal contraceptives
Safety Risks Unknown long-term safety : Effects on human tissues, including potential for fibrosis or unwanted angiogenesis, are not known
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
Postintervention data demonstrated a marked reduction in inappropriate PPI injections: the number of cases without proper indications decreased from 276 (63.89%) to 5 (10.42%), whereas the number of dosage and administration errors declined from 66 (15.29%) to 7 (14.58%)
If there is neurological involvement, Cyanocobalamin may be given in doses of 1000 micrograms on alternate days and continued for as long as improvement occurs
This creates effects that translate into antidepressant, anxiolytic, and neuroprotective actions in animal models